22.07.10 Allschwil / Marseille - The Swiss biotech company Actelion pays EUR10m to get a first hand on French Trophos SA. The two companies entered a binding agreement whereby Actelion has time till the end of 2011 to decide over an...
more
10.07.10 Third-generation DNA sequencers seem likely to hit the US$1bn sequencing market in 3-5 years, and insiders predict the new machines will bring down sequencing costs for a full human genome to a mere one hundred euros. Diagnostics...
more
10.07.10 Epalinges – Swiss Mymetics S.A. has sucessfully completed Phase Ib testing of its promising malaria vaccine candidate, which targets both the liver (sporozoite) and the blood form (merozoite) of the malaria parasite Plasmodium...
more
30.06.10 Geneva – Conversion of biomass to biofuels, chemicals, energy and heat has the potential to create a US$295 bn market by the year 2030 and create 800,000 new jobs, according to a report published by the World Economic Forum...
more
21.06.10 Basel – The US Food and Drug Administration (FDA) has approved Tasigna (nilotinib) 150 mg pills for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in...
more
